Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jun 10, 2022 8-K
4 Jun 2, 2022 FORM 4 SUBMISSION
SC 13G May 31, 2022
SC 13G May 19, 2022
10-Q May 13, 2022 10-Q
8-K May 12, 2022 8-K
4 May 4, 2022 FORM 4 SUBMISSION
DEFA14A Apr 27, 2022 DEFA14A
DEF 14A Apr 27, 2022 DEF 14A
4 Apr 5, 2022 FORM 4 SUBMISSION
8-K Apr 5, 2022 8-K
S-8 Mar 11, 2022 S-8
10-K Mar 11, 2022 10-K
8-K Mar 10, 2022 8-K
4 Mar 3, 2022 FORM 4 SUBMISSION
SC 13G/A Feb 14, 2022 SCHEDULE 13G/A, AMENDMENT # 2
SC 13G/A Feb 14, 2022 SC 13G/A
SC 13G/A Feb 14, 2022 VIRIDIAN THERAPEUTICS, INC.
SC 13G/A Feb 14, 2022 SC 13G/A
SC 13G/A Feb 14, 2022
SC 13G/A Feb 14, 2022
SC 13G/A Feb 14, 2022 AMENDMENT NO. 1 TO THE SCHEDULE 13G
SC 13G/A Feb 14, 2022 VIRIDIAN THERAPEUTICS, INC.
SC 13G Feb 14, 2022 SC 13G
SC 13G/A Feb 11, 2022 SC 13G/A
← Newer Page 12 of 33 · 817 filings Older →